@PMOIndia @ORDI @Cipla_Global , @SunPharma_Live , @LupinGlobal, @Bharathbiotech Win-win Business Opportunity.
Vertex produces and sells CF meds for exorbitant cost. Many from non first world countries suffer and do not have access to these drugs which are out of patients reach.
Read: ๐
"One company holds a monopoly on the manufacture and sale of CFTR modulator therapies and is choosing not to make new CF treatments available to people in the developing world through the normal channels..."
- that co. is @VertexPharma
Link:๐ฒ
https://t.co/0UUq0U4xOf